Figure 5
From: DOF-binding sites additively contribute to guard cell-specificity of AtMYB60promoter
Expression of the GUS gene in different transgenic lines in response to ABA treatment. Two lines for each construct shown in Figure 2 were analysed by Real Time RT-PCR. c represent the control samples. The transcript amount in the sample -1307 A control was arbitrarily set to 1 and used to normalize the relative expression levels in each line. The ACTIN2 gene was used as a control.